MaxCyte Inc (NASDAQ:MXCT), a global cell-based therapies and life sciences company, has recently witnessed a significant insider sell by its President and CEO, Douglas Doerfler.
MaxCyte, Inc. (LON:MXCT – Get Free Report) insider John Johnston sold 200 shares of the stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of GBX 453 ($5.72), for a total transaction of £906 ($1,144.37). MaxCyte Stock Down 0.7 % MXCT opened at GBX 375 ($4.74) […]